enVVeno Medical NVNO
NASDAQ NVNO
$6.65 -0.26 (-3.76%)
At close: Oct 23, 2026 · 4:00 PM EDT

enVVeno Medical (NVNO) Cost of Revenue (2017)

Updated

enVVeno Medical (NVNO) reported Cost of Revenue of $97,984 for Q4 2017, down 26.3% from the prior quarter.

Analysis

enVVeno Medical (NVNO) Cost of Revenue (2017) Analysis & Trends

For FY2017, enVVeno Medical posted Cost of Revenue of $419,659.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Thermo Fisher Scientific 249.17 Bn 228.32 Bn 4.88 Bn 7.11 Bn
2 Abbott Laboratories 179.42 Bn 150.51 Bn 7.27 Bn 5.33 Bn
3 Danaher 161.98 Bn 145.80 Bn 3.61 Bn 2.65 Bn
4 Intuitive Surgical 156.76 Bn 137.18 Bn 2.08 Bn 964.40 Mn
5 Medtronic 122.13 Bn 88.00 Bn 6.34 Bn 3.42 Bn
6 Stryker 117.84 Bn 103.96 Bn 4.50 Bn 2.09 Bn
7 Boston Scientific 66.19 Bn 61.20 Bn 3.85 Bn 1.59 Bn
8 Becton Dickinson 54.16 Bn 51.31 Bn 2.32 Bn 2.67 Bn
9 Edwards Lifesciences 51.35 Bn 35.47 Bn 1.35 Bn 392.40 Mn
10 enVVeno Medical 4.48 Mn -101.10 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 97,984.00
Sep 30, 2017 132,941.00
API Access

enVVeno Medical Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=NVNO&period=max&api_key=YOUR_API_KEY